Key Resources Table from A Transcriptome-Based Precision Oncology Platform for Patient–Therapy Alignment in a Diverse Set of Treatment-Resistant Malignancies
Oncogenic KRAS mutations are absent in approximately 10% of patients with metastatic pancreatic ductal adenocarcinoma (mPDAC) and may represent a subgroup of mPDAC with therapeutic options beyond stan
Supplemental material, sj-xlsx-2-cix-10.1177_11769351221135141 for A transcriptome-Based Deep Neural Network Classifier for Identifying the Site of Origin in Mucinous Cancer by Taejin Ahn, Kidong Kim,
Acute myeloid leukaemia (AML) is a heterogeneous haematological malignancy caused by mutations in genes encoding transcriptional and epigenetic regulators together with signalling genes. It is charact
This project collects the genomic and transcriptomic data generated for Tenthredo distinguenda to facilitate genome assembly and annotation as part of the Darwin Tree of Life Project (https://www.darw